Bolus injection of contrast agents with various iodine concentrations and <font color="blue">delivery_1</font> <font color="blue">rates_1</font> <font color="blue">for_1</font> <font color="blue">intracranial_1</font> <font color="blue">three_1</font> <font color="blue">-_1</font> <font color="blue">dimensional_1</font> <font color="blue">CT_1</font> <font color="blue">angiography_1</font> <font color="blue">:_1</font> <font color="blue">evaluation_2</font> <font color="blue">of_2</font> <font color="blue">intracranial_3</font> <font color="blue">arteriovenous_3</font> <font color="blue">contrast_3</font> <font color="blue">using_1</font> <font color="blue">a_1</font> <font color="blue">multidetector_2</font> <font color="blue">-_2</font> <font color="blue">row_2</font> <font color="blue">CT_2</font> <font color="blue">scanner_2</font> <font color="blue">._2</font> <font color="blue">
<br>
<br>_1</font> PURPOSE We evaluated <font color="blue">the_1</font> <font color="blue">difference_2</font> <font color="blue">in_2</font> <font color="blue">computed_2</font> <font color="blue">tomography_2</font> <font color="blue">(_2</font> <font color="blue">CT_2</font> <font color="blue">)_2</font> <font color="blue">attenuation_2</font> <font color="blue">values_2</font> <font color="blue">of_2</font> <font color="blue">the_2</font> <font color="blue">intracranial_2</font> <font color="blue">arterial_2</font> <font color="blue">and_2</font> <font color="blue">venous_2</font> <font color="blue">systems_2</font> <font color="blue">among_1</font> <font color="blue">the_1</font> <font color="blue">various_1</font> <font color="blue">contrast_1</font> <font color="blue">injection_1</font> <font color="blue">protocols_1</font> <font color="blue">(_1</font> <font color="blue">higher_1</font> <font color="blue">iodine_1</font> <font color="blue">delivery_1</font> <font color="blue">rate_1</font> <font color="blue">or_1</font> <font color="blue">higher_1</font> <font color="blue">concentration_1</font> <font color="blue">of_1</font> <font color="blue">the_1</font> <font color="blue">agent_1</font> <font color="blue">)_1</font> <font color="blue">on_1</font> <font color="blue">the_1</font> <font color="blue">source_1</font> <font color="blue">images_1</font> <font color="blue">of_1</font> <font color="blue">intracranial_1</font> <font color="blue">three_1</font> <font color="blue">-_1</font> <font color="blue">dimensional_1</font> <font color="blue">CT_1</font> <font color="blue">angiography_1</font> <font color="blue">(_1</font> <font color="blue">3D_1</font> <font color="blue">-_1</font> <font color="blue">CTA_1</font> <font color="blue">)_1</font> <font color="blue">using_1</font> <font color="blue">a_1</font> <font color="blue">multidetector_2</font> <font color="blue">-_2</font> <font color="blue">row_2</font> <font color="blue">CT_2</font> <font color="blue">(_2</font> <font color="blue">MDCT_2</font> <font color="blue">)_2</font> <font color="blue">scanner_2</font> <font color="blue">._2</font> 
<br> MATERIALS AND METHODS We used 100 ml of <font color="blue">iopamidol_1</font> <font color="blue">300_1</font> at an injection rate of 3.0 ml / s , 100 ml of iopamidol 300 at an injection rate of 3.7 ml / s , and 80 ml of iopamidol 370 at an injection rate of 3.0 ml / s . There were 10 patients in each group . <font color="blue">Attenuation_3</font> <font color="blue">values_3</font> <font color="blue">of_3</font> <font color="blue">the_3</font> <font color="blue">bilateral_4</font> <font color="blue">internal_4</font> <font color="blue">carotid_4</font> <font color="blue">arteries_4</font> <font color="blue">(_4</font> <font color="blue">ICAs_4</font> <font color="blue">)_4</font> <font color="blue">,_4</font> <font color="blue">basilar_4</font> <font color="blue">artery_4</font> <font color="blue">trunk_4</font> <font color="blue">,_4</font> <font color="blue">bilateral_4</font> <font color="blue">cavernous_4</font> <font color="blue">sinuses_4</font> <font color="blue">(_4</font> <font color="blue">CSs_4</font> <font color="blue">)_4</font> <font color="blue">,_4</font> <font color="blue">and_4</font> <font color="blue">Galenic_4</font> <font color="blue">vein_4</font> <font color="blue">were_2</font> <font color="blue">measured_2</font> <font color="blue">quantitatively_2</font> <font color="blue">on_2</font> <font color="blue">the_2</font> <font color="blue">axial_2</font> <font color="blue">CT_2</font> <font color="blue">angiographic_2</font> <font color="blue">source_2</font> <font color="blue">images_2</font> <font color="blue">obtained_1</font> <font color="blue">by_1</font> <font color="blue">four_1</font> <font color="blue">-_1</font> <font color="blue">channel_1</font> <font color="blue">MDCT_1</font> <font color="blue">._1</font> <font color="blue">
<br>_1</font> RESULTS Injection of the high - concentration contrast with a higher iodine - delivery rate achieved <font color="blue">good_2</font> <font color="blue">arteriovenous_4</font> <font color="blue">contrast_4</font> <font color="blue">at_2</font> <font color="blue">the_2</font> <font color="blue">cavernous_2</font> <font color="blue">portion_2</font> <font color="blue">._2</font> With the same rate of iodine delivery , injection of the intermediate concentrate agent <font color="blue">increased_1</font> <font color="blue">the_1</font> <font color="blue">CT_3</font> <font color="blue">value_3</font> <font color="blue">of_1</font> <font color="blue">not_1</font> <font color="blue">only_1</font> <font color="blue">the_1</font> <font color="blue">ICAs_2</font> <font color="blue">but_1</font> <font color="blue">also_1</font> <font color="blue">the_1</font> <font color="blue">CSs_2</font> <font color="blue">._2</font> 
<br> CONCLUSION High - concentration contrast could increase <font color="blue">ICA_4</font> <font color="blue">attenuation_4</font> <font color="blue">without_1</font> <font color="blue">intracavernous_1</font> <font color="blue">attenuation_1</font> <font color="blue">gain_1</font> during the " first - pass " phase .